A biomedical startup that licensed a Purdue University technology has developed a late-stage prostate cancer therapy that could provide an alternative to current hormone therapies that are known to develop resistance after prolonged use.

A new type of imaging technology uses the mid-infrared part of the spectrum and "thermal lensing" to visualize living cells and organisms, an innovation that could bring insights into drug delivery and cancer treatment.

Professor Edward Delp has received the 2017 SPIE Technology Achievement Award. The SPIE Technology Achievement award is awarded annually to recognize outstanding technical accomplishment in optics, electro-optics, photonic engineering, or imaging.

Liesl Krause received the 2016 Society for Applied Spectroscopy (SAS) Undergraduate Student Award which recognizes undergraduate researchers for their contributions in the field of spectroscopy.

The National Science Foundation has awarded a $300,000 grant to a team of Purdue University researchers to study the complex issues surrounding the lack of diversity and inclusivity in engineering.

The Fearnot-Laufman-Greatbatch Award is given each year to the BME or IBSc graduate student who gives the best BME summer seminar presentation, as determined by audience member evaluations.

A team of five biomedical engineering undergraduates who created and prototyped an economically feasible method for diagnosing tuberculosis in small children has won first prize in the 2016 Design by Biomedical Undergraduate Teams (DEBUT) Challenge competition.

Taylor Moehling, a graduate student at Purdue's Weldon School of Biomedical Engineering, has returned from Haiti where she worked on developing new techniques for collection, culture and detection of Vibrio cholera (cholera) bacteria from local water sources. Moehling received the national Whitaker Foundation grant, which enabled her to conduct research abroad. She is advised by Jacqueline Linnes, assistant professor of biomedical engineering, who specializes in developing mobile, inexpensive diagnostic tools for detecting and monitoring infections diseases.

A new ultra-high resolution "nanoscope" is capable of taking 3-D images of an entire cell and its cellular constituents in unprecedented detail, an advance that could reveal biological phenomena never before seen and bring new medical insights.

A new tumor model has been shown to predict how certain types of cancer cells react differently to a commonly used chemotherapy drug, a potential tool for "precision medicine," in which drug treatment is tailored to individual patients and certain cancer types.